60 Seconds with... Stephen Mitchell, GSK

Although almost 2 years since the pandemic brought supply chains to a standstill, the aftershocks are still being felt. We spoke to Stephen Mitchell, Compliance & Quality Manager at GSK, to see how he’s looking to the future.

Following two years of upheaval due to Covid-19, which are the biggest goals for you in your role currently?

The biggest goals are coping with the aftermath and current ongoing supply chain disruption to global distribution.

What is your primary challenge in building the supply chain of the future?

The primary challenge is GDP compliant resilience and flexibility.

What are you most looking forward to at LogiPharma 2022?

I’m most looking forward to the opportunity to meet peers again face to face.

You can hear directly from Stephen at LogiPharma 2022,  on his panel discussion with:

Torben Weilmuenster, Global Head of Supply Chain Management, Merz, Volker Cloos, Head of Supply Chain & Logistics Asia, Eli Lilly, Brice Bellin, Director Healthcare & Life Sciences, Bollore on  'How can you best collaborate on sea freight operations, following global disruption, to benefit from leverage on the economies of scale and achieve more reliable delivery and 'How have recent events in sea freight affected pharmaceutical shipment efforts and where are the challenges and opportunities.'

Find out what are the greatest ongoing challenges to the project and to industry-wide adoption, how are these challenges being overcome, and what lessons have been learned from the project. Book here to secure your ticket before they sell out!